104 related articles for article (PubMed ID: 15079792)
41. Analysis of the C609T polymorphism of NQO1 gene in South Croatian patients with hematological malignancies.
Lozić B; Primorac D; Glavinić R; Samija RK; Zemunik T
Coll Antropol; 2011 Jun; 35(2):385-8. PubMed ID: 21755707
[TBL] [Abstract][Full Text] [Related]
42. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
[TBL] [Abstract][Full Text] [Related]
43. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
44. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
45. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
Liu P; Liu Z; Shao M; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
[TBL] [Abstract][Full Text] [Related]
46. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
47. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
[TBL] [Abstract][Full Text] [Related]
48. [Relation of genetic polymorphism of NQO1 and GSTT1 with risks of chronic benzene poisoning].
Wan J; Shi J; Guan J; Ye R; Gao X; Liu W; Hui L; Cao D; Jin X; Hu G; Xia Z
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Oct; 20(5):340-3. PubMed ID: 14694720
[TBL] [Abstract][Full Text] [Related]
49. Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders.
Pae CU; Yoon SJ; Patkar AA; Kim JJ; Lee C; Paik IH
Psychiatry Res; 2007 Sep; 153(1):83-6. PubMed ID: 17644186
[TBL] [Abstract][Full Text] [Related]
50. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
51. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients.
Malik E; Cohen SB; Sahar D; Dann EJ; Rund D
Haematologica; 2006 Jul; 91(7):956-9. PubMed ID: 16818284
[TBL] [Abstract][Full Text] [Related]
52. High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.
Zachaki S; Stavropoulou C; Koromila T; Manola KN; Kalomoiraki M; Daraki A; Koumbi D; Athanasiadou A; Kanavakis E; Kollia P; Sambani C
Leuk Res; 2013 Jul; 37(7):742-6. PubMed ID: 23643325
[TBL] [Abstract][Full Text] [Related]
53. Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia.
Begleiter A; Hewitt D; Gibson SB; Johnston JB
Leuk Res; 2009 Jan; 33(1):74-81. PubMed ID: 18676018
[TBL] [Abstract][Full Text] [Related]
54. High risk of 'de novo' acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects.
Yamaguti GG; Lourenço GJ; Costa FF; Lima CS
Eur J Haematol; 2009 Sep; 83(3):270-2. PubMed ID: 19456854
[No Abstract] [Full Text] [Related]
55. [Relationship between the Fnu4HI site polymorphism of monoamine oxidase A gene and Parkinson's disease].
Jiang XH; Yang H; Yang JF; Dong XM; Xu QY; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):211-4. PubMed ID: 12778446
[TBL] [Abstract][Full Text] [Related]
56. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
[TBL] [Abstract][Full Text] [Related]
57. Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Fidani L
Neurosci Lett; 2013 Apr; 541():190-2. PubMed ID: 23473716
[TBL] [Abstract][Full Text] [Related]
58. [Association between polymorphism of dopamine β-hydroxylase gene and Parkinson's disease in Uygurs and Hans of Xinjiang].
Li Y; Zhang X; Han X; Guo M; Zou M; Wang L; Li Y; Xiao Y; Zeng W; Song Q
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):808-12. PubMed ID: 24854745
[TBL] [Abstract][Full Text] [Related]
59. Detection of (NAD(P)H:Quinone oxidoreductase-1, EC 1.6.99.2) 609C-->T and 465C-->T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP.
Phillips RM; Basu S; Brown JE; Flannigan GM; Loadman PM; Martin SW; Naylor B; Puri R; Shah T
Int J Oncol; 2004 Apr; 24(4):1005-10. PubMed ID: 15010841
[TBL] [Abstract][Full Text] [Related]
60. Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease.
Hua P; Liu W; Zhao Y; Ding H; Wang L; Xiao H
Sleep Med; 2012 Mar; 13(3):297-300. PubMed ID: 22257907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
